Probing cancer signaling with resonant waveguide grating biosensors

Bibliography

• Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99
   PubMed Web of Science ®Google Scholar
• Weinstein IB. Cancer. Addiction to oncogenes – the Achilles heal of cancer. Science 2002;297:63-4
   PubMed Web of Science ®Google Scholar
• Weinstein IB, Joe A. Oncogene addiction. Cancer Res 2008;68:3077-80
   PubMed Web of Science ®Google Scholar
• Wood LD, Parsons DW, Jones S, The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13
   PubMed Web of Science ®Google Scholar
• Jones S, Zhang X, Parsons DW, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6
   PubMed Web of Science ®Google Scholar
• Sjoblom T, Jones S, Wood LD, The consensus coding sequences of human breast and colorectal cancers. Nature 2008;455:1061-8
   PubMedGoogle Scholar
• Parsons DW, Jones S, Zhang X, An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-12
   PubMed Web of Science ®Google Scholar
• Schlabach MR, Luo J, Solimini NL, Cancer proliferation gene discovery through functional genomics. Science 2008;319:620-4
   PubMed Web of Science ®Google Scholar
• Lin J, Gan CM, Zhang X, A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res 2009;17:1304-18
   Web of Science ®Google Scholar
• Velculescu VE. Defining the blueprint of the cancer genome. Carcinogenesis 2008;29:1087-91
   PubMed Web of Science ®Google Scholar
• Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002;2:331-41
   PubMed Web of Science ®Google Scholar
• Gymnopoulos M, Elsliger MA, Vogt PK. Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci USA 2007;104:5569-74
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82
   PubMed Web of Science ®Google Scholar
• Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009;136:823-37
   PubMed Web of Science ®Google Scholar
• Fang Y. Label-free cell-based assays with optical biosensors in drug discovery. Assays Drug Dev Technol 2006;4:583-95
   PubMed Web of Science ®Google Scholar
• Fang Y. Non-invasive optical biosensor for probing cell signaling. Sensors 2007;7:2316-29
   PubMed Web of Science ®Google Scholar
• Kenakin T. Interrogating 7TM receptors: does texture in the question yield greater texture in the answer? J Receptors Signal Transduction 2009;29:132-9
   PubMed Web of Science ®Google Scholar
• Kenakin T. Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nat Rev Drug Discov 2009;8:617-26
   PubMed Web of Science ®Google Scholar
• Fang Y, Frutos AG, Verkleeren R. Label-free cell assays for GPCR screening. Comb Chem HTS 2008;11:357-69
   Web of Science ®Google Scholar
• Fang Y, Ferrie AM, Fontaine NH, Resonant waveguide grating biosensor for living cell sensing. Biophys J 2006;91:1925-40
   PubMed Web of Science ®Google Scholar
• Ramsden JJ, Horvath R. Optical biosensors for cell adhesion. J Receptors Signal Transduction 2009;29:211-23
   PubMed Web of Science ®Google Scholar
• Tiefenthaler K, Lukosz W. Sensitivity of grating couplers as integrated-optical chemical sensors. J Opt Soc Am B 1989;6:209-20
   Web of Science ®Google Scholar
• Fang Y, Ferrie AM, Fontaine NH, Yuen PK. Characteristics of dynamic mass redistribution of EGF receptor signaling in living cells measured with label free optical biosensors. Anal Chem 2005;77:5720-5
   PubMed Web of Science ®Google Scholar
• Horvath R, Cottier K, Pedersen HC, Ramsden JJ. Mutlidepth screening of living cells using optical waveguide. Biosens Bioelectron 2008;24:799-804
   Web of Science ®Google Scholar
• Barer R, Joseph S. Refractometry of living cells. Part I. basic principles. Quart J Microsc Sci 1954;95:399-423
   Google Scholar
• Kholodenko BN. Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors. J Exper Biol 2003;206:2073-82
   PubMed Web of Science ®Google Scholar
• Shumay E, Gavi S, Wang HY, Malbon CC. Trafficking of beta 2-adrenergic receptors: insulin and beta 2-agonists regulate internalization by distinct cytoskeletal pathways. J Cell Sci 2004;117:593-600
   PubMed Web of Science ®Google Scholar
• Fang Y, Ferrie AM. Label-free optical biosensor for ligand-directed functional selectivity of acting on beta 2 adrenoceptor in living cells. FEBS Lett 2008;582:558-64
   PubMed Web of Science ®Google Scholar
• Fang Y. Label-free biosensor cellular assays for cell adhesion. J Adhesion Sci Technol 2010;24:1011-21
   Web of Science ®Google Scholar
• Owens RM, Wang Q, You JA, Real-time quantitation of viral replication and inhibitor potency using a label-free optical biosensor. J Receptors Signal Transduction 2009;29:195-201
   PubMed Web of Science ®Google Scholar
• Ramsden JJ, Li SY, Prenosil JE, Heinzle E. Optical method for measurement of number and shape of attached cells in real time. Cytometry 1995;19:97-102
   PubMedGoogle Scholar
• Voros J, Graf R, Kenausis GL, Feasibility study of an online toxicological sensor based on the optical waveguide technique. Biosens Bioelectron 2000;15:423-9
   PubMed Web of Science ®Google Scholar
• Fang Y, Li G, Ferrie AM. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. J Pharmacol Toxicol Methods 2007;55:314-22
   PubMedGoogle Scholar
• Henstridge CM, Balenga NAB, Schroder R, GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol 2010;160:604-14
   PubMed Web of Science ®Google Scholar
• Flemin MR, Kaczmarek LK. Use of optical biosensors to detect modulation of Slack potassium channels by G protein-coupled receptors. J Receptors Signal Transduction 2009;29:173-81
   PubMed Web of Science ®Google Scholar
• Du Y, Li Z, Li L, Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells. J Receptors Signal Transduction 2009;29:182-94
   PubMed Web of Science ®Google Scholar
• Tran E, Fang Y. Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling. J Receptors Signal Transduction 2009;29:154-62
   PubMed Web of Science ®Google Scholar
• Fang Y, Ferrie AM, Li G. Probing cytoskeleton modulation by optical biosensors. FEBS Lett 2005;579:4175-80
   PubMed Web of Science ®Google Scholar
• Fang Y, Li G, Peng J. Optical biosensor provides insights for bradykinin B2 receptor signaling in A431 cells. FEBS Lett 2005;579:6365-74
   PubMed Web of Science ®Google Scholar
• Peters MF, Vaillancourt F, Heroux M, Comparing label-free biosensors for pharmacological screening with cell-based functional assays. Assay Drug Dev Technol 2010;8:219-27
   PubMed Web of Science ®Google Scholar
• Schroeder R, Merten N, Mathiesen JM, The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai- and downstream-signaling cascade activation. J Biol Chem 2009;284:1324-36
   PubMed Web of Science ®Google Scholar
• Lee PH, Gao A, van Staden C, Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed G protein-coupled receptors. Assay Drug Dev Technol 2008;6:83-93
   PubMed Web of Science ®Google Scholar
• Cooper MA. Signal transduction profiling using label-free biosensors. J Receptors Signal Transduction 2009;29:224-33
   PubMed Web of Science ®Google Scholar
• Rocheville M, Jerman JC. 7TM pharmacology measured by label-free: a holistic approach to cell signaling. Curr Opin Pharmacol 2009;9:643-9
   PubMed Web of Science ®Google Scholar
• Jiang J, Ganesh T, Du Y, Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc Natl Acad Sci USA 2010;107:2307-12
   PubMed Web of Science ®Google Scholar
• Kebig A, Kostenis E, Mohr K, Mohr-Andra M. An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators. J Receptors Signal Transduction 2009;29:140-5
   PubMed Web of Science ®Google Scholar
• Fang Y, Ferrie AM. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells. BMC Cell Biol 2007;8:e24
   PubMedGoogle Scholar
• Fang Y. Label-free receptor assays. Drug Discov Today Technol 2010;7. DOI: 10.1016/j.ddtec.2010.05.001
   Google Scholar
• Tran E, Fang Y. Duplexed label-free G protein-coupled receptor assays for high throughput screening. J Biomol Screen 2008;13:975-85
   PubMed Web of Science ®Google Scholar
• Stockwell BR. Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 2000;1:116-25
   PubMed Web of Science ®Google Scholar
• Hannon GJ. RNA interference. Nature 2002;418:244-51
   PubMed Web of Science ®Google Scholar
• Stockwell BR. Exploring biology with small organic molecules. Nature 2004;432:846-54
   PubMed Web of Science ®Google Scholar
• Kuruvilla FG, Shamji AF, Sternson SM, Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 2002;416:653-7
   PubMed Web of Science ®Google Scholar
• Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006;6:813-23
   PubMed Web of Science ®Google Scholar
• Weinstein JN, Myers TG, O'Connor PM, An information-intensive approach to the molecular pharmacology of cancer. Science 1997;275:343-9
   PubMed Web of Science ®Google Scholar
• Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007;7:169-81
   PubMed Web of Science ®Google Scholar
• Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8
   PubMed Web of Science ®Google Scholar
• Zourob M, Elwary S, Fan X, Label-free detection with the resonant mirror biosensor. Methods Mol Biol Biosens Biodetection 2008;503:89-138
   Google Scholar
• Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47:624-30
   PubMed Web of Science ®Google Scholar
• Martins CP, Brown-Swigart L, Evan GI. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006;127:1323-34
   PubMed Web of Science ®Google Scholar
• Ventura A, Kirsch DG, McLaughlin ME, Restoration of p53 function leads to tumour regression in vivo. Nature 2007;445:661-5
   PubMed Web of Science ®Google Scholar
• Xue W, Zender L, Miething C, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-60
   PubMed Web of Science ®Google Scholar
• Kaiser J. Cancer. First pass at cancer genome reveals complex landscape. Science 2006;313:1370
   PubMed Web of Science ®Google Scholar
• Kim KJ, Li B, Winer J, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362:841-4
   PubMed Web of Science ®Google Scholar
• Obata K, Morland SJ, Watson RH, Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 1998;58:2095-7
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-8
   PubMed Web of Science ®Google Scholar
• Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 1999;4:199-207
   PubMed Web of Science ®Google Scholar
• Jain M, Arvanitis C, Chu K, Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 2002;297:102-4
   PubMed Web of Science ®Google Scholar
• Pelengaris S, Littlewood T, Khan M, Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 1999;3:565-77
   PubMed Web of Science ®Google Scholar
• Huettner CS, Zhang P, van Etten RA, Tenen DG. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000;24:57-60
   PubMed Web of Science ®Google Scholar
• Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993;260:85-8
   PubMed Web of Science ®Google Scholar
• Cui Q, Ma Y, Jaramillo M, A map of human cancer signaling. Mol Systems Biol 2007;3:152
   PubMed Web of Science ®Google Scholar
• Hudis CA. Trastuzumab--mechanism of action and use in clinical practice. New Engl J Med 2007;357:39-51
   PubMed Web of Science ®Google Scholar
• Druker BJ, Lydon NB. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 2000;105:3-7
   PubMed Web of Science ®Google Scholar
• Cragg MS, Kuroda J, Puthalakath H, Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med 2007;4:e316
   Google Scholar
• Petty TL. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 2003;1:3-4
   Google Scholar
• Taguchi T, Tsukuda M, Imagawa-Ishiguro Y, Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib. Oncol Rep 2008;19:65-71
   PubMed Web of Science ®Google Scholar
• Peterson AW, Halter M, Tona A, Surface plasmon resonance imaging of cells and surface-associated fibronectin. BMC Cell Biol 2009;10:e16
   PubMedGoogle Scholar
• Ziblat R, Lirtsman V, Davidov D, Aroeti B. Infrared surface plasmon resonance: a novel tool for real time sensing of variations in living cells. Biophys J 2006;90:2592-9
   PubMed Web of Science ®Google Scholar